BDBM38807 2-(2,4-dimethylanilino)-7-(2-furanyl)-7,8-dihydro-6H-quinazolin-5-one::2-(2,4-dimethylanilino)-7-(2-furyl)-7,8-dihydro-6H-quinazolin-5-one::2-(2,4-dimethylanilino)-7-(furan-2-yl)-7,8-dihydro-6H-quinazolin-5-one::2-[(2,4-dimethylphenyl)amino]-7-(furan-2-yl)-7,8-dihydro-6H-quinazolin-5-one::MLS000041773::SMR000046745::cid_665672

SMILES Cc1ccc(Nc2ncc3C(=O)CC(Cc3n2)c2ccco2)c(C)c1

InChI Key InChIKey=PACPHBIBQHVQKU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 38807   

TargetM-phase inducer phosphatase 2(Human)
University of Pittsburgh

Curated by PubChem BioAssay
LigandPNGBDBM38807(2-(2,4-dimethylanilino)-7-(2-furanyl)-7,8-dihydro-...)
Affinity DataIC50: 5.00E+4nMAssay Description:The Cdc25B Phosphatase HTS dose response confirmation has been developed to confirm actives identified in the Cdc25B HTS AID 368, screened at the Uni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2011
Entry Details
PCBioAssay